X

Health Care

Cara Therapeutics Q1 loss widens but beats estimates

Cara Therapeutics Inc. (NASDAQ: CARA) reported a wider loss in the first quarter of 2019 due to higher costs and expenses.…

Earnings preview: ‘Joint’ venture with Altria to help Cronos Group in Q1

Come Thursday and Cronos Group (NASDAQ: CRON) officially kicks off another season of cannabis stock earnings. The Toronto-based marijuana firm…

MannKind posts narrower-than-expected Q1 loss

MannKind Corporation (NASDAQ: MNKD) reported a narrower loss in the first quarter of 2019 helped by higher total revenues. The…

Earnings: Array BioPharma reports upbeat Q3 results

Array BioPharma (NASDAQ: ARRY) reported a narrower-than-expected loss in the third quarter of 2019, sending its shares up 0.5% during…

Mylan reports Q1 earnings beat on weak revenues, confirms 2019 outlook

Mylan’s (MYL) stock plunged about 5% in the pre-market trading after the company’s revenues failed to meet estimates. However, adjusted…

Allergan beats estimates on Q1 results, raises full-year guidance

Allergan plc (NYSE: AGN) topped market forecasts on revenue and earnings for the first quarter of 2019. Despite the beat,…

Regeneron Q1 profit falls 4%, misses estimates

Regeneron Pharmaceuticals (NASDAQ: REGN) reported a 4% decline in earnings for the first quarter of 2019 due to higher costs…

GW Pharmaceuticals’ stock climbs on Q1 results beat

Medical marijuana company GW Pharmaceuticals (NASDAQ: GWPH) beat market expectations on revenue and earnings for the first quarter of 2019,…

Bausch Health’s stock gains on improved outlook

Bausch Health Companies Inc. (NYSE: BHC) missed revenue expectations for the first quarter of 2019 and did not provide a…

Earnings preview: What to expect when Allergan reports Q1 2019 earnings results

Allergan plc (NYSE: AGN) is scheduled to report earnings results for the first quarter of 2019 on Tuesday, May 7,…